Trials / Recruiting
RecruitingNCT04662905
Novel Treatment Delivery of ECAP-controlled Closed-loop SCS for Chronic Pain
A Prospective, Multicentre, Single-arm Feasibility Study Examining Novel Treatment Delivery of the Evoke Spinal Cord Stimulator (SCS) System to Treat Patients With Chronic Pain of the Trunk and/or Limbs
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- Saluda Medical Pty Ltd · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to test and evaluate novel treatment delivery of ECAP-controlled closed loop SCS through the incorporation of new software and/or hardware features for patients with the Evoke System.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Evoke Spinal Cord Stimulation (SCS) System | ECAP-controlled, closed-loop SCS |
Timeline
- Start date
- 2020-12-15
- Primary completion
- 2027-01-01
- Completion
- 2027-01-01
- First posted
- 2020-12-10
- Last updated
- 2025-05-13
Locations
23 sites across 1 country: Australia
Source: ClinicalTrials.gov record NCT04662905. Inclusion in this directory is not an endorsement.